{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:08Z","timestamp":1786981508254,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hallym Medical Center Academic-Industrial Cooperation Program","award":["2016-323-I"],"award-info":[{"award-number":["2016-323-I"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11033-021-06331-y","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T12:02:15Z","timestamp":1628942535000},"page":"6231-6240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-4963","authenticated-orcid":false,"given":"Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Mi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Han","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,14]]},"reference":[{"key":"6331_CR1","doi-asserted-by":"publisher","first-page":"34250","DOI":"10.1074\/jbc.M704075200","volume":"282","author":"JD Amaral","year":"2007","unstructured":"Amaral JD, Castro RE, Sola S, Steer CJ, Rodrigues CM (2007) p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol Chem 282:34250\u201334259. https:\/\/doi.org\/10.1074\/jbc.M704075200","journal-title":"J Biol Chem"},{"key":"6331_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","volume":"50","author":"JD Amaral","year":"2009","unstructured":"Amaral JD, Viana RJ, Ramalho RM, Steer CJ, Rodrigues CM (2009) Bile acids: regulation of apoptosis by ursodeoxycholic acid. J Lipid Res 50:1721\u20131734. https:\/\/doi.org\/10.1194\/jlr.R900011-JLR200","journal-title":"J Lipid Res"},{"key":"6331_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5009\/gnl15568","volume":"11","author":"B Blechacz","year":"2017","unstructured":"Blechacz B (2017) Cholangiocarcinoma: current knowledge and new developments. Gut and liver 11:13\u201326. https:\/\/doi.org\/10.5009\/gnl15568","journal-title":"Gut and liver"},{"key":"6331_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","volume":"40","author":"B Brandsaeter","year":"2004","unstructured":"Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40:815\u2013822. https:\/\/doi.org\/10.1016\/j.jhep.2004.01.002","journal-title":"J Hepatol"},{"key":"6331_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/jhep.2002.32931","volume":"35","author":"ME Guicciardi","year":"2002","unstructured":"Guicciardi ME, Gores GJ (2002) Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. Hepatology 35:971\u2013973. https:\/\/doi.org\/10.1053\/jhep.2002.32931","journal-title":"Hepatology"},{"key":"6331_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/jhep.2001.28198","volume":"34","author":"N Hayashi","year":"2001","unstructured":"Hayashi N, Yamamoto H, Hiraoka N, Dono K, Ito Y, Okami J, Kondo M, Nagano H, Umeshita K, Sakon M, Matsuura N, Nakamori S, Monden M (2001) Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 34:638\u2013650. https:\/\/doi.org\/10.1053\/jhep.2001.28198","journal-title":"Hepatology"},{"key":"6331_CR7","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","volume":"67","author":"GM Hirschfield","year":"2018","unstructured":"Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, H\u00fcbscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ (2018) The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 67:1568\u20131594. https:\/\/doi.org\/10.1136\/gutjnl-2017-315259","journal-title":"Gut"},{"key":"6331_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/01635580701883003","volume":"60","author":"S Khare","year":"2008","unstructured":"Khare S, Mustafi R, Cerda S, Yuan W, Jagadeeswaran S, Dougherty U, Tretiakova M, Samarel A, Cohen G, Wang J, Moore C, Wali R, Holgren C, Joseph L, Fichera A, Li YC, Bissonnette M (2008) Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT\/enhancer-binding protein. Nutr Cancer 60:389\u2013400. https:\/\/doi.org\/10.1080\/01635580701883003","journal-title":"Nutr Cancer"},{"key":"6331_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/mph.0000000000000329","volume":"37","author":"D King","year":"2015","unstructured":"King D, Yeomanson D, Bryant HE (2015) PI3King the lock: targeting the PI3K\/Akt\/mTOR pathway as a novel therapeutic strategy in neuroblastoma. J Pediatr Hematol Oncol 37:245\u2013251. https:\/\/doi.org\/10.1097\/mph.0000000000000329","journal-title":"J Pediatr Hematol Oncol"},{"key":"6331_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sj.bjc.6600440","volume":"87","author":"JL Ku","year":"2002","unstructured":"Ku JL, Yoon KA, Kim IJ, Kim WH, Jang JY, Suh KS, Kim SW, Park YH, Hwang JH, Yoon YB, Park JG (2002) Establishment and characterisation of six human biliary tract cancer cell lines. Br J Cancer 87:187\u2013193. https:\/\/doi.org\/10.1038\/sj.bjc.6600440","journal-title":"Br J Cancer"},{"key":"6331_CR11","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.7150\/jca.26380","volume":"10","author":"J Lee","year":"2019","unstructured":"Lee J, Hong EM, Kim JH, Jung JH, Park SW, Koh DH, Choi MH, Jang HJ, Kae SH (2019) Metformin induces apoptosis and inhibits proliferation through the AMP-activated protein kinase and insulin-like growth factor 1 receptor pathways in the bile duct cancer cells. J Cancer 10:1734\u20131744. https:\/\/doi.org\/10.7150\/jca.26380","journal-title":"J Cancer"},{"key":"6331_CR12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3892\/ijmm.2018.3807","volume":"42","author":"S Lee","year":"2018","unstructured":"Lee S, Cho YY, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ (2018) Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK. Int J Mol Med 42:2551\u20132559. https:\/\/doi.org\/10.3892\/ijmm.2018.3807","journal-title":"Int J Mol Med"},{"key":"6331_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3892\/or.2012.1918","volume":"28","author":"SC Lim","year":"2012","unstructured":"Lim SC, Duong HQ, Parajuli KR, Han SI (2012) Pro-apoptotic role of the MEK\/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. Oncol Rep 28:1429\u20131434. https:\/\/doi.org\/10.3892\/or.2012.1918","journal-title":"Oncol Rep"},{"key":"6331_CR14","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3748\/wjg.v13.i11.1652","volume":"13","author":"H Liu","year":"2007","unstructured":"Liu H, Qin CY, Han GQ, Xu HW, Meng M, Yang Z (2007) Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. World J Gastroenterol: WJG 13:1652\u20131658. https:\/\/doi.org\/10.3748\/wjg.v13.i11.1652","journal-title":"World J Gastroenterol: WJG"},{"key":"6331_CR15","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.3748\/wjg.v21.i36.10367","volume":"21","author":"H Liu","year":"2015","unstructured":"Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, Wei LL, Qin CY, Qin CK (2015) Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol: WJG 21:10367\u201310374. https:\/\/doi.org\/10.3748\/wjg.v21.i36.10367","journal-title":"World J Gastroenterol: WJG"},{"key":"6331_CR16","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.yexcr.2009.04.009","volume":"315","author":"H Matsuoka","year":"2009","unstructured":"Matsuoka H, Tsubaki M, Yamazoe Y, Ogaki M, Satou T, Itoh T, Kusunoki T, Nishida S (2009) Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC\/MEK\/ERK and PKC\/PI3K\/Akt pathways. Exp Cell Res 315:2022\u20132032. https:\/\/doi.org\/10.1016\/j.yexcr.2009.04.009","journal-title":"Exp Cell Res"},{"key":"6331_CR17","doi-asserted-by":"publisher","first-page":"e23414","DOI":"10.1371\/journal.pone.0023414","volume":"6","author":"L Ojeda","year":"2011","unstructured":"Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, Gao T, Wu P (2011) Critical role of PI3K\/Akt\/GSK3beta in motoneuron specification from human neural stem cells in response to FGF2 and EGF. PLoS ONE 6:e23414. https:\/\/doi.org\/10.1371\/journal.pone.0023414","journal-title":"PLoS ONE"},{"key":"6331_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, Folvik G, Bell H, Gangsoy-Kristiansen M, Matre J, Rydning A, Wikman O, Danielsson A, Sandberg-Gertzen H, Ung KA, Eriksson A, Loof L, Prytz H, Marschall HU, Broome U (2005) High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129:1464\u20131472. https:\/\/doi.org\/10.1053\/j.gastro.2005.08.017","journal-title":"Gastroenterology"},{"key":"6331_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj20050908","volume":"392","author":"RJ Orton","year":"2005","unstructured":"Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W (2005) Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J 392:249\u2013261. https:\/\/doi.org\/10.1042\/bj20050908","journal-title":"Biochem J"},{"key":"6331_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/carcin\/23.5.885","volume":"23","author":"K Oyama","year":"2002","unstructured":"Oyama K, Shiota G, Ito H, Murawaki Y, Kawasaki H (2002) Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 23:885\u2013892. https:\/\/doi.org\/10.1093\/carcin\/23.5.885","journal-title":"Carcinogenesis"},{"key":"6331_CR21","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3390\/nu7053200","volume":"7","author":"L Pang","year":"2015","unstructured":"Pang L, Zhao X, Liu W, Deng J, Tan X, Qiu L (2015) Anticancer Effect of ursodeoxycholic acid in human oral squamous carcinoma HSC-3 cells through the caspases. Nutrients 7:3200\u20133218. https:\/\/doi.org\/10.3390\/nu7053200","journal-title":"Nutrients"},{"key":"6331_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 130:715\u2013720. https:\/\/doi.org\/10.1053\/j.gastro.2005.12.029","journal-title":"Gastroenterology"},{"key":"6331_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/bf02974038","volume":"20","author":"YH Park","year":"1997","unstructured":"Park YH, Kim JA, Baek JH, Jung EJ, Kim TH, Suh H, Park MH, Kim KW (1997) Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA). Arch Pharm Res 20:29\u201333. https:\/\/doi.org\/10.1007\/bf02974038","journal-title":"Arch Pharm Res"},{"key":"6331_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/dneu.20506","volume":"67","author":"J Peltier","year":"2007","unstructured":"Peltier J, O\u2019Neill A, Schaffer DV (2007) PI3K\/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67:1348\u20131361. https:\/\/doi.org\/10.1002\/dneu.20506","journal-title":"Dev Neurobiol"},{"key":"6331_CR25","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3748\/wjg.15.1677","volume":"15","author":"MJ Perez","year":"2009","unstructured":"Perez MJ, Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol: WJG 15:1677\u20131689. https:\/\/doi.org\/10.3748\/wjg.15.1677","journal-title":"World J Gastroenterol: WJG"},{"key":"6331_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MEG.0b013e3281108068","volume":"19","author":"G Rudolph","year":"2007","unstructured":"Rudolph G, Kloeters-Plachky P, Rost D, Stiehl A (2007) The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Eur J Gastroenterol Hepatol 19:487\u2013491. https:\/\/doi.org\/10.1097\/MEG.0b013e3281108068","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6331_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.gcb.2010.05.005","volume":"34","author":"L Serfaty","year":"2010","unstructured":"Serfaty L, Bissonnette M, Poupon R (2010) Ursodeoxycholic acid and chemoprevention of colorectal cancer. Gastroenterol Clin Biol 34:516\u2013522. https:\/\/doi.org\/10.1016\/j.gcb.2010.05.005","journal-title":"Gastroenterol Clin Biol"},{"key":"6331_CR28","first-page":"1393","volume":"26","author":"B Singh","year":"2005","unstructured":"Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A (2005) COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26:1393\u20131399","journal-title":"Int J Oncol"},{"key":"6331_CR29","first-page":"208","volume":"13","author":"GW Song","year":"2007","unstructured":"Song GW, Lee SG, Lee YJ, Park KM, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH (2007) Analysis of survival and factors affecting the survival after surgical resection of peripheral cholangiocarcinoma: 318 cases in single institute. Korean J Hepatol 13:208\u2013221","journal-title":"Korean J Hepatol"},{"key":"6331_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ncb1875","volume":"11","author":"SP Wang","year":"2009","unstructured":"Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH, Yuan A, Lin CW, Yang SC, Chan WK, Li KC, Hong TM, Yang PC (2009) p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 11:694\u2013704. https:\/\/doi.org\/10.1038\/ncb1875","journal-title":"Nat Cell Biol"},{"key":"6331_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbcan.2005.04.002","volume":"1755","author":"T Wu","year":"2005","unstructured":"Wu T (2005) Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma. Biochem Biophys Acta 1755:135\u2013150. https:\/\/doi.org\/10.1016\/j.bbcan.2005.04.002","journal-title":"Biochem Biophys Acta"},{"key":"6331_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/jhep.2001.22702","volume":"33","author":"B Yerushalmi","year":"2001","unstructured":"Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ (2001) Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33:616\u2013626. https:\/\/doi.org\/10.1053\/jhep.2001.22702","journal-title":"Hepatology"},{"key":"6331_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1053\/gast.2002.32410","volume":"122","author":"JH Yoon","year":"2002","unstructured":"Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, Gores GJ (2002) Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122:985\u2013993. https:\/\/doi.org\/10.1053\/gast.2002.32410","journal-title":"Gastroenterology"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06331-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06331-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06331-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T14:28:48Z","timestamp":1631543328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06331-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,14]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6331"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06331-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,14]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confirm that all data underlying the findings are fully available without restriction and have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable to the approval because this study was performed using cells purchased from the Korean Cell Line Bank (KCLB).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}